Related Experiment Video
Updated: May 14, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Tumor Microenvironment-Responsive Polymer Delivery Platforms for Cancer Therapy
Yiqi Shi1, Qianqian Yu1, Lijie Tan2
1Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Shanghai Key Laboratory of Functional Materials Chemistry, Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, Frontiers Science Center for Materiobiology and Dynamic Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, 200237, P.R. China.
Abstract:
Most chemotherapeutic and bioimaging agents struggle with inadequate bioavailability, primarily due to their limited biocompatibility and lack of specificity in targeting, leading to low or decreased anticancer efficacy and inaccurate imaging. To surmount these obstacles, the development of stimuli-responsive polymer delivery platforms, predominantly leveraging the tumor microenvironment (TME), has emerged as a promising strategy. Therapeutic and diagnostic agents can be released controllably at the tumor site by virtue of the bond cleavage or hydrophobic to hydrophilic transformation of TME-sensitive linkages in TME-responsive systems, thus augmenting cancer treatment and imaging precision, while simultaneously attenuating the damage to healthy tissues and false imaging signals caused by non-specific drug leakage. In this comprehensive review, we scrutinize recent studies of TME-responsive polymer delivery platforms, encompassing pH-, ROS-, GSH-, enzyme-, and hypoxia-responsive vectors, significantly from the perspective of their molecular design and responsive mechanism, and further summarizing their bio-application in drug delivery and diagnostic imaging. Moreover, this review encapsulates the critical challenges and offers an insightful perspective on the future prospects of TME-responsive polymer delivery platforms in terms of molecular and vector design.
Insights
Stimuli-responsive polymer delivery platforms, leveraging the tumor microenvironment (TME), enhance anticancer drug delivery and bioimaging. These TME-responsive systems improve targeting precision and reduce damage to healthy tissues.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Chemotherapeutic and bioimaging agents often suffer from poor bioavailability, limited biocompatibility, and lack of specific targeting.
- This leads to reduced anticancer efficacy and inaccurate diagnostic imaging, posing significant challenges in cancer treatment.
Purpose of the Study:
- To review recent advancements in stimuli-responsive polymer delivery platforms that utilize the tumor microenvironment (TME).
- To analyze the molecular design and responsive mechanisms of these platforms.
- To summarize their applications in drug delivery and diagnostic imaging for cancer.
Main Methods:
- Comprehensive literature review of TME-responsive polymer delivery systems.
- Analysis of platforms responding to pH, reactive oxygen species (ROS), glutathione (GSH), enzymes, and hypoxia.
- Examination of molecular design, responsive mechanisms, and bio-applications.
Main Results:
- TME-responsive polymer platforms offer controlled release of therapeutic and diagnostic agents at the tumor site.
- These systems improve targeting specificity, enhancing anticancer treatment efficacy and imaging precision.
- They also minimize damage to healthy tissues and reduce false imaging signals from non-specific drug leakage.
Conclusions:
- TME-responsive polymer delivery platforms represent a promising strategy to overcome limitations of conventional cancer therapies and diagnostics.
- Further research into molecular and vector design is crucial for optimizing their performance.
- These platforms hold significant potential for future advancements in precision oncology.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy

